Nieman, Gary
Kollisch-Singule, Michaela
Ramcharran, Harry
Satalin, Joshua
Blair, Sarah
Gatto, Louis A.
Andrews, Penny
Ghosh, Auyon
Kaczka, David W.
Gaver, Donald
Bates, Jason
Habashi, Nader M.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R01HL142702)
Congressionally Directed Medical Research Programs (W81XWH-20-1-0696)
Article History
Received: 13 April 2022
Accepted: 12 July 2022
First Online: 7 August 2022
Declarations
:
: Not applicable.
: Not applicable.
: MKS has received a Research Grant and GF an Unrestricted Educational Grant from Dräger Medical Systems, Inc. PLA, GFN, MKS, and NMH have presented and received honoraria and/or travel reimbursement at event(s) sponsored by Dräger Medical Systems, Inc., outside of the published work. PLA, GFN, MKS, and NMH have lectured for Intensive Care Online Network, Inc. (ICON). NMH is the founder of ICON, of which PLA is an employee. NMH holds patents on a method of initiating, managing and/or weaning airway pressure release ventilation, as well as controlling a ventilator in accordance with the same, but these patents are not commercialized, licensed, or royalty-producing. The authors maintain that industry had no role in the design and conduct of the study; the collection, management, analysis, or interpretation of the data; nor the preparation, review, or approval of the manuscript. Dr. Kaczka is a co-founder and shareholder of OscillaVent, Inc., and is a co-inventor on a patent involving multi-frequency oscillatory ventilation. Dr. Kaczka also receives research support from ZOLL Medical Corporation and is a paid consultant for Lungpacer Medical, Inc. Dr. Bates is a consultant to and sharehold in OscillaVent, Inc., and has two patents pending in the field of MV.